Sounds like typical pharma pricing. Drugs that have no competition (branded or generic) are priced high and companies like GoodRx and CostPlus are not able to negotiate lower prices.
And you're not naive enough to expect altruism in the American capital system???
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.